Issue 1/2017
Content (22 Articles)
International lessons in new methods for grading and integrating cost effectiveness evidence into clinical practice guidelines
Kathryn M. Antioch, Michael F. Drummond, Louis W. Niessen, Hindrik Vondeling
Economic evaluation of participatory learning and action with women’s groups facilitated by Accredited Social Health Activists to improve birth outcomes in rural eastern India
Rajesh Kumar Sinha, Hassan Haghparast-Bidgoli, Prasanta Kishore Tripathy, Nirmala Nair, Rajkumar Gope, Shibanand Rath, Audrey Prost
Costs and savings associated with a pharmacists prescribing for minor ailments program in Saskatchewan
Ellen Rafferty, Mohsen Yaghoubi, Jeff Taylor, Marwa Farag
Cost-effectiveness analysis of the national decentralization policy of antiretroviral treatment programme in Zambia
Shinsuke Miyano, Gardner Syakantu, Kenichi Komada, Hiroyoshi Endo, Tomohiko Sugishita
Defining a staged-based process for economic and financial evaluations of mHealth programs
Amnesty E. LeFevre, Samuel D. Shillcutt, Sean Broomhead, Alain B. Labrique, Tom Jones
Efficiency and productivity assessment of public hospitals in Greece during the crisis period 2009–2012
P. Xenos, J. Yfantopoulos, M. Nektarios, N. Polyzos, P. Tinios, A. Constantopoulos
Economic evaluations of vaccines in Canada: a scoping review
Ellen R. S. Rafferty, Heather L. Gagnon, Marwa Farag, Cheryl L. Waldner
Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemia
Anthony J. Hatswell, Gwilym J. Thompson, Penny A. Maroudas, Oleg Sofrygin, Thomas E. Delea
Cost-effectiveness analysis of the diarrhea alleviation through zinc and oral rehydration therapy (DAZT) program in rural Gujarat India: an application of the net-benefit regression framework
Samuel D. Shillcutt, Amnesty E. LeFevre, Christa L. Fischer-Walker, Sunita Taneja, Robert E. Black, Sarmila Mazumder
Cost-effectiveness analysis of malaria interventions using disability adjusted life years: a systematic review
Resign Gunda, Moses John Chimbari
Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
Francesco Saverio Mennini, Paolo Bonanni, Florence Bianic, Chiara de Waure, Gianluca Baio, Giacomo Plazzotta, Mathieu Uhart, Alessandro Rinaldi, Nathalie Largeron
Modeling the potential impact of emerging innovations on achievement of Sustainable Development Goals related to maternal, newborn, and child health
Tara Herrick, Claudia Harner-Jay, Craig Shaffer, Greg Zwisler, Peder Digre, Amie Batson
Cost-effectiveness of cervical cancer screening and preventative cryotherapy at an HIV treatment clinic in Kenya
Marita R. Zimmermann, Elisabeth Vodicka, Joseph B. Babigumira, Timothy Okech, Nelly Mugo, Samah Sakr, Louis P. Garrison, Michael H. Chung
Cost effectiveness of pre-referral antimalarial treatment in severe malaria among children in sub-Saharan Africa
Vivian Rakuomi, Faith Okalebo, Stanley Ndwigah, Levi Mbugua
Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
Phil McEwan, Samantha Webster, Thomas Ward, Michael Brenner, Anupama Kalsekar, Yong Yuan
Public engagement in setting healthcare priorities: a ranking exercise in Cyprus
Antonis Farmakas, Mamas Theodorou, Petros Galanis, Georgios Karayiannis, Stefanos Ghobrial, Nikos Polyzos, Evridiki Papastavrou, Eirini Agapidaki, Kyriakos Souliotis
Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in Malaysia
Xiao Jun Wang, Ashwini Saha, Xu-Hao Zhang
Cost-effectiveness of human papillomavirus vaccination in Germany
Oliver Damm, Johannes Horn, Rafael T. Mikolajczyk, Mirjam E. E. Kretzschmar, Andreas M. Kaufmann, Yvonne Deleré, Bernhard Ultsch, Ole Wichmann, Alexander Krämer, Wolfgang Greiner
Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece
Hara Kousoulakou, Magdalini Hatzikou, Varvara Baroutsou, John Yfantopoulos
Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates
Stephanie Harvard, Daphne Guh, Nick Bansback, Pascal Richette, Alain Saraux, Bruno Fautrel, Aslam Anis
Disease control programme support costs: an update of WHO-CHOICE methodology, price databases and quantity assumptions
Melanie Y. Bertram, Karin Stenberg, Callum Brindley, Jina Li, Juliana Serje, Rory Watts, Tessa Tan-Torres Edejer
Lifetime cost-effectiveness analysis of intraoperative radiation therapy versus external beam radiation therapy for early stage breast cancer
Rakesh Patel, Olga Ivanov, Jeff Voigt